** @BioProtocol is pioneering the future of biotech with AI-powered decentralized science (DeSci). Recently raising $6.9M led by Maelstrom Fund, the project is building a full-stack platform to accelerate biotech funding and drug discovery through AI-native frameworks and onchain innovation.
With the launch of Bio V2, researchers, patients, and the crypto community can leverage BioAgents to generate scientific hypotheses, monetize discoveries, and uncover hidden insights far faster than traditional models. Its first BioAgent, developed with VitaDAO and Dr. Aubrey de Grey, achieved explosive success: the $AUBRAI token surged 150X while minting over 1,000 hypotheses onchain.
Expanding globally, @BioProtocol aims to create a network of decentralized science engines that reshape how biotech research is funded and developed.
#BIO $BIO
3.94K
0
The content on this page is provided by third parties. Unless otherwise stated, OKX is not the author of the cited article(s) and does not claim any copyright in the materials. The content is provided for informational purposes only and does not represent the views of OKX. It is not intended to be an endorsement of any kind and should not be considered investment advice or a solicitation to buy or sell digital assets. To the extent generative AI is utilized to provide summaries or other information, such AI generated content may be inaccurate or inconsistent. Please read the linked article for more details and information. OKX is not responsible for content hosted on third party sites. Digital asset holdings, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition.